Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 292149

Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid - how to treat it?


Paštar, Zrinjka; Radoš, Jaka; Lipozenčić, Jasna; Dobrić, Ivan; Marinović, Branka; Ishii, Norito, Hashimoto, Takashi
Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid - how to treat it? // International journal of dermatology, 46 (2007), 3; 295-298 doi:10.1111/j.1365-4632.2006.02969.x (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 292149 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid - how to treat it?

Autori
Paštar, Zrinjka ; Radoš, Jaka ; Lipozenčić, Jasna ; Dobrić, Ivan ; Marinović, Branka ; Ishii, Norito, Hashimoto, Takashi

Izvornik
International journal of dermatology (0011-9059) 46 (2007), 3; 295-298

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
epidermolysis bullosa acquisita; anti-p200 pemphigoid; treatment

Sažetak
Epidermolysis bullosa acquisita (EBA) is an uncommon, chronic, acquired, autoimmune, subepidermal blistering disease. The etiology of the disease is unknown. EBA antibodies bind to type VII collagen within anchoring fibrils at the dermo-epidermal junction. This results in a decreased number of anchoring fibrils, which therefore do not anchor the epidermis and its underlying basement membrane to the papillary dermis. To date, five clinical presentations of EBA have been described. 1 In general, the clinical features of classical EBA include increased skin fragility and skin lesions on the areas predisposed to trauma. EBA also affects the mucous membranes. The first two cases of EBA were reported and distinguished from dystrophic epidermolysis bullosa by Elliot in 1895. We present a patient with clinical, histological and immunological features of a mixture of EBA and anti-p200 pemphigoid.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
0108166
108-0000000-0105 - Autoimune bulozne dermatoze u Republici Hrvatskoj (Marinović, Branka, MZOS ) ( POIROT)

Ustanove:
Medicinski fakultet, Zagreb

Citiraj ovu publikaciju

Paštar, Zrinjka; Radoš, Jaka; Lipozenčić, Jasna; Dobrić, Ivan; Marinović, Branka; Ishii, Norito, Hashimoto, Takashi
Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid - how to treat it? // International journal of dermatology, 46 (2007), 3; 295-298 doi:10.1111/j.1365-4632.2006.02969.x (međunarodna recenzija, članak, znanstveni)
Paštar, Z., Radoš, J., Lipozenčić, J., Dobrić, I., Marinović, B. & Ishii, Norito, Hashimoto, Takashi (2007) Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid - how to treat it?. International journal of dermatology, 46 (3), 295-298 doi:10.1111/j.1365-4632.2006.02969.x.
@article{article, year = {2007}, pages = {295-298}, DOI = {10.1111/j.1365-4632.2006.02969.x}, keywords = {epidermolysis bullosa acquisita, anti-p200 pemphigoid, treatment}, journal = {International journal of dermatology}, doi = {10.1111/j.1365-4632.2006.02969.x}, volume = {46}, number = {3}, issn = {0011-9059}, title = {Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid - how to treat it?}, keyword = {epidermolysis bullosa acquisita, anti-p200 pemphigoid, treatment} }
@article{article, year = {2007}, pages = {295-298}, DOI = {10.1111/j.1365-4632.2006.02969.x}, keywords = {epidermolysis bullosa acquisita, anti-p200 pemphigoid, treatment}, journal = {International journal of dermatology}, doi = {10.1111/j.1365-4632.2006.02969.x}, volume = {46}, number = {3}, issn = {0011-9059}, title = {Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid - how to treat it?}, keyword = {epidermolysis bullosa acquisita, anti-p200 pemphigoid, treatment} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font